ISOGENICA

Isogenica Ltd

Application Filed: 2010-01-22

Trademark Application Details

Status

706

Live/Registered

SECTION 71 ACCEPTED

Research	OneLook Acronym Finder
Serial Number	79084070
Registration Number	3980235
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Jamie L Dupree
Law Office Assigned	L30
Employee Name	HAYES, GINA CLARK

Timeline

2010-01-22	Application Filed
2011-04-05	Published for Opposition
2011-06-21	Trademark Registered
2017-12-08	Location: GENERIC WEB UPDATE
2017-12-08	Status: Live/Registered
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Isogenica Ltd
Entity Statement	Public Limited Company
Address	The Mansion, Chesterford Reserch Park Little Chesterford Cambridgeshire GB CB10 1XL
Legal Entity Type
Legal Entity State	GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Jamie L Dupree
FUTTERMAN DUPREE DODD CROLEY MAIER LLP
601 Montgomery Street
Suite 333
SAN FRANCISCO, CA 94104

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	42
U.S. Codes:	100,101
International Codes:	45
U.S. Codes:	100,101

Type Code	Type
GS0051	Diagnostic and therapeutic synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical use; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Type Code

Type

GS0051

Diagnostic and therapeutic synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical use; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB	2010-07-22	1 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2010-07-23	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2010-07-23	3 DOCK D:Assigned to Examiner
APPLICATION FILING RECEIPT MAILED	2010-07-27	4 MAFR O:Outgoing Correspondence
NON-FINAL ACTION WRITTEN	2010-07-27	5 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	2010-07-28	6 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU	2010-07-28	7 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	2010-07-28	8 RFCS P:
REFUSAL PROCESSED BY IB	2010-08-28	9 RFNP P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2010-10-08	10 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2010-10-08	11 ARAA I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2011-01-26	12 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2011-01-26	13 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2011-01-27	14 TEME I:Incoming Correspondence
FINAL REFUSAL WRITTEN	2011-02-18	15 CNFR R:Renewal
FINAL REFUSAL E-MAILED	2011-02-18	16 GNFR O:Outgoing Correspondence
NOTIFICATION OF FINAL REFUSAL EMAILED	2011-02-18	17 GNFN O:Outgoing Correspondence
EXAMINERS AMENDMENT -WRITTEN	2011-02-24	18 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2011-02-24	19 GNEA O:Outgoing Correspondence
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2011-02-24	20 GNEN O:Outgoing Correspondence
ASSIGNED TO LIE	2011-02-24	21 ALIE A:Allowance for Publication
EXAMINER'S AMENDMENT ENTERED	2011-02-24	22 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2011-02-25	23 CNSA O:Outgoing Correspondence
LAW OFFICE PUBLICATION REVIEW COMPLETED	2011-02-25	24 PREV O:Outgoing Correspondence
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	2011-03-17	25 OP2R P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	2011-03-17	26 OPNS P:
PUBLISHED FOR OPPOSITION	2011-04-05	27 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2011-04-05	28 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2011-06-21	29 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	2011-09-21	30 FICR P:
FINAL DISPOSITION PROCESSED	2011-11-17	31 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB	2011-11-17	32 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB	2013-03-03	33 FINO P:
NEW REPRESENTATIVE AT IB RECEIVED	2015-02-13	34 NREP P:
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2017-09-19	35 TCCA I:Incoming Correspondence
TEAS SECTION 71 RECEIVED	2017-11-13	36 ES71 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2017-12-06	37 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED	2017-12-08	38 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2017-12-08	39 NA71 E:E-Mail
INTERNATIONAL REGISTRATION RENEWED	2020-02-06	40 RNWL P:
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED	2020-06-21	41 REM4 E:E-Mail
TEAS SECTION 71 RECEIVED	2021-06-21	42 ES71 I:Incoming Correspondence
NEW REPRESENTATIVE AT IB RECEIVED	2021-08-13	43 NREP P:
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2021-12-08	44 APRE A:Allowance for Publication
REGISTERED-SEC.71 ACCEPTED	2022-02-24	45 71AG O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED	2022-02-24	46 NA71 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.